The hexarelin report examines how a hormone response changes over repeated exposure. It is not a trial of a consumer cycling strategy. Primary report
Study observations
Twelve healthy older adults were followed during 16 weeks of hexarelin exposure. The GH area under the curve declined over time, with significant reductions reported at later assessments. After a four-week interval following completion, a renewed challenge produced a larger response than at week 16. The investigators described the attenuation as partial and reversible in this study. Primary report
Our appraisal: response recovery is not validation of a regimen
A challenge test after a break can show that a measured biological response changed. It cannot, by itself, establish that repeated cycles improve symptoms, body composition, longevity, or safety. Those are additional hypotheses needing their own controlled evaluation.
Nor does the word “reversible” mean every consequence of exposure was assessed and reversed. It refers here to the observed GH-response attenuation, within the measurement period. Precise wording prevents a narrow finding from becoming a broad reassurance.
Full review should inspect whether an appropriate untreated comparator was present, how the challenge tests were standardized, and whether the same participants contributed at every time point. A before-and-after sequence can be affected by changes other than the proposed mechanism.
The result also belongs beside shorter studies rather than being treated as contradictory solely because their conclusions differ. Different routes, durations, populations, and response measures can produce different observations. The comparison requires design details, not just titles.
Frequently asked questions
Was the GH response constant over 16 weeks?
No. It attenuated.
Was the attenuation complete?
The report describes it as partial.
Did the response increase after the follow-up interval?
Yes, in the reported challenge assessment.
Does that validate a cycling protocol?
No. Clinical benefit and safety of such a protocol were not established.
Does reversible GH attenuation mean every effect reversed?
No. The term is specific to the measured response.
Can short studies be compared solely by their conclusions?
No. Their designs and observation periods must be matched.
What source was inspected?
The primary indexed abstract; complete methods and safety review remain pending.